Viapiana Ombretta, Gatti Davide, Dalle Grave Riccardo, Todesco Tiziana, Rossini Maurizio, Braga Vania, Idolazzi Luca, Fracassi Elena, Adami Silvano
Department of Rheumathology, University of Verona, Valeggio Hospital, 37067 Valeggio S/Mincio, Verona, Italy.
Bone. 2007 Apr;40(4):1073-7. doi: 10.1016/j.bone.2006.11.015. Epub 2007 Jan 19.
Anorexia nervosa (AN) is a life-threatening eating disorder characterized by an inability to maintain a normal body weight and amenorrhoea, often associated with osteoporosis and increased risk of fragility fractures. Bone metabolism, including markers of bone turnover (serum total alkaline phosphatase, bone alkaline phosphatase [bone AP], osteocalcin [OC] and type I collagen C-telopeptide breakdown products [sCTX]) and bone mineral density (BMD) by dual energy X-ray absorptiometry (DXA) at the spine and at the hip, were evaluated in 55 consecutive women with AN undergoing a 3-month intensive nutritional rehabilitation program. The control group was constituted of 25 healthy young medical students. In AN patients body weight increased during the 3-month nutritional program from 37.8+/-5.1 (mean+/-SD) to 51.5+/-4.5 kg. The corresponding BMI rose to values >17.5 kg/m(2) in all patients. Mean BMD significantly rose by 2.6+/-3.5% and 1.1+/-3.6% at the hip and at the spine, respectively. The markers of bone formation, serum bone AP and osteocalcin, significantly rose by two-folds, while sCTX decreased by 16%. The changes in hip BMD were positively related (p<0.005) to changes in body weight and in bone AP (p<0.02) while the changes in spine BMD were positively related to changes in serum osteocalcin (p<0.05). In the 25 patients who attended the 12-month posttreatment control, mean body weight significantly decreased by 3.6+/-6.0 kg and this was not associated with any significant change in BMD values. In the patients in whom BMI fell again below 17.5 kg/m(2) hip BMD values decreased significantly. On the contrary, in the patients who maintained BMI >17.5 kg/m(2), BMD values continued to rise up to values over the 15-month observation of 4.8+/-6.2 and 7.1+/-12.1 at the spine and hip, respectively. In conclusion, we have demonstrated that substantial gains in weight in women with chronic AN are associated with remarkable increases in BMD at both the hip and the spine. If weight is maintained, the overall improvement approach 1 SD within 1 year. The changes in both weight and BMD are correlated with improvements in bone formation markers and diminutions in a marker of bone resorption.
神经性厌食症(AN)是一种危及生命的饮食失调症,其特征是无法维持正常体重和闭经,常伴有骨质疏松症和脆性骨折风险增加。对55名连续接受为期3个月强化营养康复计划的AN女性患者,评估了骨代谢,包括骨转换标志物(血清总碱性磷酸酶、骨碱性磷酸酶[骨AP]、骨钙素[OC]和I型胶原C末端肽降解产物[sCTX])以及通过双能X线吸收法(DXA)测量的脊柱和髋部骨密度(BMD)。对照组由25名健康年轻医学生组成。在AN患者中,3个月营养计划期间体重从37.8±5.1(均值±标准差)增加到51.5±4.5kg。所有患者的相应体重指数(BMI)升至>17.5kg/m²。髋部和脊柱的平均BMD分别显著升高2.6±3.5%和1.1±3.6%。骨形成标志物血清骨AP和骨钙素显著升高两倍,而sCTX降低16%。髋部BMD的变化与体重变化和骨AP变化呈正相关(p<0.005),而脊柱BMD的变化与血清骨钙素变化呈正相关(p<0.05)。在参加12个月后续治疗对照评估的25名患者中,平均体重显著下降3.6±6.0kg,且这与BMD值的任何显著变化无关。在BMI再次降至<17.5kg/m²的患者中,髋部BMD值显著下降。相反,在BMI维持>17.5kg/m²的患者中,在长达15个月的观察期内,脊柱和髋部的BMD值分别持续上升至4.8±6.2和7.1±12.1以上。总之,我们证明慢性AN女性体重的显著增加与髋部和脊柱BMD的显著增加相关。如果体重得以维持,总体改善在1年内接近1个标准差。体重和BMD的变化与骨形成标志物的改善以及骨吸收标志物的减少相关。